# MAYZENT

NDC: 0078-1014
Generic name: siponimod
Labeler / Manufacturer: Novartis Pharmaceuticals Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20190326

FDA application: NDA209884

## Active ingredients

- SIPONIMOD: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0078-1014"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0078-1014
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44492772-5aed-4627-bd85-e8e89f308bb3